Personalized Polypills Produced by Fused Deposition Modeling 3D Printing

Qi, Sheng ORCID: https://orcid.org/0000-0003-1872-9572, Nasereddin, Jehad and Alqahtani, Fahad (2019) Personalized Polypills Produced by Fused Deposition Modeling 3D Printing. In: 3D and 4D Printing in Biomedical Applications. Wiley, pp. 273-295. ISBN 9783527344437

Full text not available from this repository.

Abstract

Personalized medicine in the literature commonly refers to using patient's genetic information to enable therapeutic decisions tailored to an individual patient. Personalized pills containing more than one drug are referred as polypills, which is a term exclusively used in the treatment of cardiovascular diseases (CVD) in the literature, but the usage is expanded to cover a range of pills that combine many medicines to provide a single solid dosage form that allows the patients to self‐administer easily. Polypharmacy is used in the medical literature to describe the co‐administration of multiple medications to patients who may have multiple comorbidities. There are a number of critical process parameters (CPPs) controlling the quality of fused deposition modeling (FDM) 3D printing. Two common methods of preparing drug‐loaded filaments have been reported in the pharmaceutical literature: impregnation and extrusion. It has been widely recognized that FDM 3D printing has unique advantages for fabricating personalized polypills.

Item Type:	Book Section
Uncontrolled Keywords:	sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Science > School of Pharmacy (former - to 2024)
UEA Research Groups:	Faculty of Science > Research Groups > Pharmaceutical Materials and Soft Matter
Depositing User:	Pure Connector
Date Deposited:	07 Jun 2018 10:31
Last Modified:	24 Sep 2024 08:09
URI:	https://ueaeprints.uea.ac.uk/id/eprint/67322
DOI:	10.1002/9783527813704.ch11

Actions (login required)

View Item